Financial Performance - The company's operating revenue for 2023 was CNY 1,385,021,174.60, a decrease of 18.41% compared to CNY 1,697,628,002.32 in 2022[23]. - Net profit attributable to shareholders was CNY 64,970,898.56, down 81.56% from CNY 352,376,335.34 in the previous year[23]. - The basic earnings per share decreased by 81.03% to CNY 0.11 from CNY 0.58 in 2022[24]. - The cash flow from operating activities was CNY 194,844,487.00, a decline of 44.09% compared to CNY 348,487,635.45 in 2022[23]. - The total assets increased by 4.3% to CNY 2,999,633,547.52 from CNY 2,875,971,632.40 in the previous year[23]. - The net profit after deducting non-recurring gains and losses was CNY 41,736,737.25, down 87.61% from CNY 336,894,642.82 in 2022[23]. - The company's net assets attributable to shareholders at the end of 2023 were CNY 1,988,713,479.46, a slight decrease of 0.92% from CNY 2,007,152,395.41 in 2022[23]. - The company achieved operating revenue of 138,502.12 million RMB, a decrease of 18.41% compared to the same period last year[32]. - The net profit attributable to shareholders was 6,497.09 million RMB, down 81.56% year-on-year, while the non-recurring net profit was 4,173.67 million RMB, a decline of 87.61%[32]. - The company's total sales revenue for the year reached 138,000,000 CNY, with the top five customers contributing 38,086,100 CNY, accounting for 27.50% of total sales[59]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of CNY 0.04 per share, totaling approximately CNY 24.49 million, representing a cash dividend payout ratio of 37.70% for the year 2023[6]. - The company declared a cash dividend of CNY 24,492,205.92, which represents 37.70% of the net profit attributable to ordinary shareholders in the consolidated financial statements[151]. - The company has set a three-year dividend return plan for shareholders from 2023 to 2025, which was also approved in the recent shareholder meeting[118]. Corporate Governance and Compliance - The company has received a standard unqualified audit report from Zhonghui Certified Public Accountants[5]. - The board of directors has confirmed that all members attended the board meeting, ensuring accountability for the report's accuracy[4]. - The company has not reported any instances where more than half of the directors could not guarantee the report's authenticity[9]. - The company has a governance structure in place that complies with relevant laws and regulations, ensuring effective decision-making and accountability[111]. - The company has held multiple board meetings and shareholder meetings, maintaining transparency and adherence to governance protocols[113]. - The company has not faced any penalties from securities regulatory agencies in the past three years, indicating compliance with regulations[131]. Risk Management - The company has outlined potential risks in its future development discussions, which investors should be aware of[9]. - The company emphasizes that forward-looking statements do not constitute substantive commitments to investors, highlighting investment risks[7]. - The company recognizes the risks associated with macroeconomic fluctuations and market competition, particularly in the functional silane sector, which is expected to grow rapidly under supportive policies[104]. - The company faces potential risks from raw material and energy price fluctuations, which could impact gross margins if costs rise significantly[104]. - The company acknowledges the risk of declining performance due to cyclical demand fluctuations in its main products, silane coupling agents and fumed silica, which are influenced by downstream industry conditions[107]. Research and Development - The company's R&D expenses amounted to CNY 40,966,663.82, down 34.09% from the previous year due to adjustments in project progress[49]. - The number of R&D personnel is 200, representing 13.5% of the total workforce, with a diverse educational background[65]. - The company has obtained 36 authorized invention patents, including 34 self-developed patents, and has submitted 4 new invention patents for acceptance in 2023[35]. - The company plans to adjust its R&D focus based on market demand, which may impact future product development strategies[49]. Environmental and Social Responsibility - The company is committed to sustainable development by enhancing safety and environmental management practices[36]. - The company has achieved a reduction of 7,982 tons in carbon dioxide equivalent emissions through implemented carbon reduction measures[172]. - The company has constructed a 150 million kcal/hour gas-liquid incinerator and a 3,000 tons/day wastewater treatment plant, addressing emissions from gas, liquid, and solid waste during production[171]. - The company has established comprehensive pollution control facilities and strictly adheres to national environmental regulations, ensuring normal operation of all pollution control systems as of the end of the reporting period[166]. - The company has disclosed its commitment to social responsibility and sustainability through a separate report, highlighting its ongoing efforts in these areas[173]. Market Position and Strategy - The company is recognized as one of the top three domestic functional silane manufacturers, holding the largest global market share for sulfur silane coupling agents since 2016[42]. - The company plans to raise up to CNY 960 million through the issuance of convertible bonds to support the integrated green materials project, which will optimize the product matrix and production capacity[101]. - The company is focusing on expanding its green circular industry chain, enhancing internal recycling of by-products, and improving production efficiency and environmental performance[98]. - The company intends to leverage its brand advantage to deepen existing markets and actively explore emerging markets, particularly in the photovoltaic and lithium battery sectors[99]. Employee and Management Changes - The company experienced a significant management turnover, with multiple directors and executives resigning due to work adjustments and term expirations[130]. - The remuneration for directors and senior management is determined based on industry standards and company performance, following the company's remuneration management guidelines[129]. - The company has established a remuneration committee to oversee the compensation of directors and senior management, ensuring transparency and accountability[129]. Future Outlook - The company anticipates a 9.4% year-on-year increase in functional silane exports in 2024, driven by a recovery in global manufacturing[96]. - The projected demand for silanes in China for 2024 is expected to reach 276,700 tons, with a production forecast of 410,300 tons[96]. - The average annual growth rate for silane production capacity from 2024 to 2028 is estimated at 14.9%[96]. - Future guidance indicates an expected revenue growth of approximately 18.38% for the next quarter, reflecting positive market conditions[121].

证券代码：605366 证券简称：宏柏新材 公告编号：2024-029 江西宏柏新材料股份有限公司 2023 年年度主要经营数据公告 注：含硫硅烷偶联剂包含产品 HP-669、HP-1589、HP669C。 二、主要产品和原材料的价格变动情况 （一）主要产品价格变动情况（不含税） | 主要产 | 2023 年年度平均销售 | 2022年年度平均销 | 变动比例 | | --- | --- | --- | --- | | 品名称 | 单价（元/吨） | 售单价（元/吨） | | | 含硫硅烷偶联剂 | 19,218.22 | 30,728.43 | -37.46% | | 气相白炭黑 | 14,898.95 | 22,537.70 | -33.89% | 注：含硫硅烷偶联剂包含产品 HP-669、HP-1589、HP669C。 一、主要产品的产量、销量及收入实现情况 主要产品 产量（吨） 销量（吨） 营业收入（万元） 含硫硅烷偶联剂 27,281.97 27,598.39 53,039.19 气相白炭黑 8,201.06 8,130.66 12,113.82 合计 35,483.03 35,729.05 65, ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 377,270,519.57, representing an increase of 18.02% compared to the same period last year[3]. - The net profit attributable to shareholders for Q1 2024 was CNY 7,075,145.30, a significant increase of 71.95% year-on-year[3]. - The company reported a decrease in net profit after deducting non-recurring gains and losses by 24.49% to CNY 2,650,677.30[3]. - The net profit for Q1 2024 was CNY 7,075,145.30, a significant increase of 72.5% compared to CNY 4,114,654.03 in Q1 2023[21]. - The total comprehensive income for Q1 2024 was CNY 7,019,512.35, compared to CNY 4,540,964.46 in Q1 2023, marking a growth of 54.5%[21]. Cash Flow - The net cash flow from operating activities was negative at CNY -33,187,381.29, a decrease of 259.12% compared to the previous year[3]. - The company reported a net cash outflow from operating activities of CNY -33,187,381.29, compared to a positive cash flow of CNY 20,856,757.62 in Q1 2023[24]. - Cash and cash equivalents at the end of Q1 2024 totaled CNY 240,752,855.78, down from CNY 359,656,687.22 at the end of Q1 2023[25]. - The cash flow from operating activities was CNY 290,682,526.89 in Q1 2024, compared to CNY 235,276,168.76 in Q1 2023[33]. - The company received $6,713,507.61 in cash related to operating activities, a notable increase from $2,372,930.59, indicating improved cash collection[34]. Assets and Liabilities - Total assets at the end of Q1 2024 amounted to CNY 3,086,397,016.34, reflecting a growth of 2.89% from the end of the previous year[4]. - Total assets as of March 31, 2024, were RMB 3,086,397,016.34, compared to RMB 2,999,633,547.52 at the end of 2023, indicating a growth of 2.91%[16]. - Total liabilities increased to RMB 1,088,179,705.97 from RMB 1,010,920,068.06, marking a rise of 7.63%[16]. - The total liabilities increased to CNY 1,197,321,364.25 in Q1 2024, compared to CNY 1,124,895,286.06 in Q4 2023[28]. - The company's total equity as of March 31, 2024, was CNY 1,923,384,997.90, slightly up from CNY 1,911,528,710.10 at the end of 2023[29]. Shareholder Information - The top shareholder, Hongbai Chemical Co., Ltd., holds 22.48% of the shares, with a total of 137,646,667 shares[10]. - The equity attributable to shareholders increased slightly by 0.48% to CNY 1,998,217,310.37 compared to the end of the previous year[4]. Operating Costs and Expenses - Total operating costs rose to CNY 376,898,102.18, up from CNY 308,559,079.30, reflecting an increase of 22.1% year-over-year[20]. - Research and development expenses increased to CNY 10,057,800.30, a rise of 32.6% from CNY 7,581,376.95 in the previous year[20]. - The company's R&D expenses for Q1 2024 were CNY 9,883,772.82, an increase of 30.4% from CNY 7,581,376.95 in Q1 2023[30]. - The company incurred a financial expense of CNY 4,193,453.14, down from CNY 7,380,390.82 in the previous year, indicating a reduction of 43.5%[20]. Government Support - The company received government subsidies amounting to CNY 5,008,180.62, contributing positively to the net profit[5]. Strategic Initiatives - The company is actively exploring new strategies for market expansion and product development, although specific details were not disclosed in the report[3].

证券代码：605366 证券简称：宏柏新材 公告编号：2024-043 江西宏柏新材料股份有限公司 注：含硫硅烷偶联剂包括 HP669、HP1589、HP669C 产品。 2024 年一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江西宏柏新材料股份有限公司(以下简称"公司")根据上海证券交易所 《上市公司行业信息披露指引第十三号——化工（2022 年修订）》有关规定， 现将 2024 年第一季度主要经营数据披露如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 2024 年 | 1-3 | 月产 | 2024 年 | 1-3 | 月销 | 2024 | 年 | 1-3 | 月销售金 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 量（吨） | | 量（吨） | | | 额（万元） | | | | | 含硫硅烷偶 联剂 | | 8,272.93 | | | | 9,259.88 | | ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605366 证券简称：宏柏新材 公告编号：2024-026 重要内容提示： 江西宏柏新材料股份有限公司 公开发行可转换公司债券发行结果公告 保荐机构（主承销商）： 江西宏柏新材料股份有限公司（以下简称"发行人"或"公司"）公开发行可转换公司 债券（以下简称"可转债"）已获得中国证券监督管理委员会证监许可〔2024〕108 号文核准。 中信证券股份有限公司（以下简称"中信证券"、"主承销商"或"保荐机构（主承销商）"） 为本次发行的保荐机构（主承销商）。本次发行的可转债简称为"宏柏转债"，债券代码为 "111019"。 | 类别 | 认购数量（手） | 放弃认购数量（手） | | --- | --- | --- | | 原股东 | 644,871 | 0 | | 网上社会公众投资者 | 305,800 | 9,329 | | 网下机构投资者 | 0 | 0 | | 主承销商包销数量（放弃 | | 9,329 | | 认购总数量） | | | | 发行数量合计 | | 9 ...

证券代码：605366 证券简称：宏柏新材 公告编号：2024-025 江西宏柏新材料股份有限公司 向不特定对象发行可转换公司债券 网上中签结果公告 保荐人（主承销商）：中信证券股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《江西宏柏新材料股份有限公司向不特定对象发行可转换公司债券发 行公告》，本次发行的发行人江西宏柏新材料股份有限公司（以下简称"宏柏 新材"）及本次发行的保荐人（主承销商）中信证券股份有限公司于 2024 年 4 月 18 日（T+1 日）主持了宏柏新材可转换公司债券（以下简称"宏柏转债"） 网上发行中签摇号仪式。摇号仪式按照公开、公平、公正的原则在有关单位代 表的监督下进行，摇号结果经上海市东方公证处公证。现将中签结果公告如下： | 末尾位数 | 中签号码 | | --- | --- | | 末"5"位数 | 67113,92113,42113,17113 | | 末"6"位数 | 417958 | | 末"7"位数 | 4526451,5776451,7026451,827645 ...

证券代码：605366 证券简称：宏柏新材 公告编号：2024-024 江西宏柏新材料股份有限公司 向不特定对象发行可转换公司债券 网上中签率及优先配售结果公告 保荐机构（主承销商）：中信证券股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 类别 | 中签率/配 售比例 | 有效申购数量 （手） | 实际配售数 量（手） | 实际获配金 额（元） | | --- | --- | --- | --- | --- | | | （%） | | | | | 原股东 | 100.00 | 644,871 | 644,871 | 644,871,000 | | 网上社会公众投资 者 | 0.00419888 | 7,505,079,737 | 315,129 | 315,129,000 | | 网下机构投资者 | - | - | - | - | | 合计 | | 7,505,724,608 | 960,000 | 960,000,000 | 特别提示 江西宏柏新材料股份有限公司（以下简称"宏柏新材"、"发行 ...

证券代码：605366 证券简称：宏柏新材 公告编号：2024-023 江西宏柏新材料股份有限公司 向不特定对象发行可转换公司债券发行提示性公告 保荐人（主承销商）：中信证券股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 特别提示 江西宏柏新材料股份有限公司（以下简称"宏柏新材"、"发行人"或"公 司"）向不特定对象发行可转换公司债券（以下简称"宏柏转债"，债券代码 "111019"）已获得中国证券监督管理委员会证监许可〔2024〕108 号文同意 注册。本次发行的保荐人（主承销商）为中信证券股份有限公司（以下简称 "中信证券"、"保荐人（主承销商）"或"主承销商"）。本次发行的《江 西宏柏新材料股份有限公司向不特定对象发行可转换公司债券募集说明书摘要》 （以下简称"《募集说明书摘要》"）、《江西宏柏新材料股份有限公司向不 特定对象发行可转换公司债券发行公告》（以下简称"《发行公告》"）及 《江西宏柏新材料股份有限公司向不特定对象发行可转换公司债券募集说明书》 （以下简称"《募集说明书》"）已于 2024 ...

股票代码：605366 证券简称：宏柏新材 公告编号： 2024-022 1 | 宏柏 | | | | | 2024 年 4 | 办理解除 | CHINA MERCHANTS BANK | | | 股东资金 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 化学 | 是 | 83,515,334 | 否 | 否 | 月 11 日 | 质押登记 | CO.,LTD.,NEW YORK | 60.67% | 13.64% | 需求 | | | | | | | | 手续之日 | BRANCH | | | | | 宏柏 | | | 否 | 否 | 2024 年 4 | 办理解除 | CHINA MERCHANTS BANK | | | 股东资金 | | 亚洲 | 是 | 70,831,931 | | | 月 11 日 | 质押登记 | CO.,LTD.,NEW YORK | 60.67% | 11.57% | 需求 | | | | | | | | 手续之日 | BRANCH | | | | | 合计 | | 154,347, ...

证券代码：605366 证券简称：宏柏新材 江西宏柏新材料股份有限公司 （江西省乐平市塔山工业园区工业九路） 向不特定对象发行可转换公司债券 募集说明书 保荐人（主承销商） 二零二四年四月 江西宏柏新材料股份有限公司 向不特定对象发行可转换公司债券募集说明书 声 明 本公司及全体董事、监事、高级管理人员承诺募集说明书及其他信息披露资 料不存在任何虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性及完整 性承担连带赔偿责任。 公司负责人、主管会计工作负责人及会计机构负责人保证募集说明书中财务 会计资料真实、完整。 中国证券监督管理委员会、上海证券交易所对本次发行所作的任何决定或意 见，均不表明其对申请文件及所披露信息的真实性、准确性、完整性作出保证， 也不表明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断 或保证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由发 行人自行负责。投资者自主判断发行人的投资价值，自主作出投资决策，自行承 担证券依法发行后因发行人经营与收益变化或者券价格变动引致的投资风险。 1-1-1 江西宏柏新材料股份有限公 ...